Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant.

Blood
Karen L SyrjalaJanet R Abrams

Abstract

Research indicates that myeloablative hematopoietic cell transplantation (HCT) impairs neurocognitive function. However, prospective studies on long-term effects are lacking. This longitudinal study examined neurocognitive changes over the first year in 142 adult recipients of allogeneic HC transplants who received neuropsychologic testing before transplantation and again after 80 days and 1 year. Age-, sex-, and education-adjusted population-based standardized scores were used for normative comparisons. Performance on all tests declined from before transplantation to 80 days (P < .05) and improved by 1 year (P < .05), returning to pretransplantation levels on all tests except for grip strength and motor dexterity. Although verbal fluency and memory recovered by 1 year, both were below norms at all 3 testing times (P < .01). Logistic regressions indicated that patients without chemotherapy, other than hydroxyurea, previous to HCT and patients not receiving chronic graft-versus-host disease (GVHD) medication at 1 year had lower risk of impaired function (P < .05). In conclusion, HCT was associated with significant generalized decline in neurocognitive performance at 80 days, with subsequent recovery to pretransplantation levels ...Continue Reading

References

Nov 1, 1992·Cancer·M A AndrykowskiP J Henslee-Downey
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C A MeyersD Przepiorka
May 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A AhlesL Mills
Dec 5, 1997·Journal of Computer Assisted Tomography·W S BartynskiD F Andrews
Mar 5, 1998·Bone Marrow Transplantation·H TezcanJ Schriber
Apr 15, 1999·Clinical Neuropharmacology·A K Shah
Feb 8, 2000·International Journal of Radiation Oncology, Biology, Physics·M PeperM Wannenmacher
Dec 21, 2000·International Journal of Radiation Oncology, Biology, Physics·F WenzM Wannenmacher
Jan 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S J LeeJ C Weeks
Jul 30, 2003·Cancer Nursing·Bernadine Cimprich, David L Ronis
May 20, 2004·JAMA : the Journal of the American Medical Association·Karen L SyrjalaPaul J Martin

❮ Previous
Next ❯

Citations

Apr 17, 2008·Neuropsychology Review·Jeffrey S WefelChristina A Meyers
Dec 15, 2006·Journal of the International Neuropsychological Society : JINS·Leigh J BeglingerRoger Gingrich
Sep 29, 2005·Hematology·H Joachim Deeg, Mary E D Flowers
Sep 22, 2009·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Melissa A FriedmanChristina A Meyers
Dec 25, 2010·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Leigh J BeglingerRoger Gingrich
Feb 9, 2013·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Mary-Ellen MeadowsE John Orav
May 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karen L SyrjalaSureyya Dikmen
May 4, 2012·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·M Wilhelm
Aug 9, 2005·Bone Marrow Transplantation·M Booth-JonesE Soety
Jul 8, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Shahrukh HashmiBipin N Savani
Aug 28, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Helena HarderMartin J van den Bent
Jun 25, 2009·Cancer·Grace ChangJoseph H Antin
Apr 23, 2008·Cancer·Kevin D SteinMichael A Andrykowski
Nov 4, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G VelikovaUNKNOWN EORTC Quality of Life Group
Aug 6, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·John R WingardMichelle M Bishop
Jul 15, 2015·Brain Imaging and Behavior·D D CorreaN Relkin
Jul 7, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Cornelio UderzoAttilio Rovelli
Jan 27, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·James R BasinskiJesse R Fann
Nov 12, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Dorothy KrolakRichard Van der Jagt
Apr 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jesse R FannKaren L Syrjala
Dec 21, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia A Ganz
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karen L SyrjalaPaul J Martin
Jul 19, 2011·Journal of Intensive Care Medicine·Aliaksei PustavoitauRobert Stevens
Dec 19, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Noha SharafeldinSmita Bhatia
Feb 23, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Noha SharafeldinSmita Bhatia
Sep 24, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Samantha J MayoJeffrey H Lipton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.